Circulating free DNA (cfDNA) and tissue next-generation sequencing analysis in a phase II study of infigratinib (BGJ398) for cholangiocarcinoma with FGFR2 fusions

被引：0
|
作者：
Makawita, Shalini
Kelley, Robin Kate
Roychowdhury, Sameek
Weiss, Karl Heinz
Abou-Alfa, Ghassan K.
Macarulla, Teresa
Sadeghi, Saeed
Waldschmidt, Dirk
Zhu, Andrew X.
Goyal, Lipika
Yong, Wei-Peng
Borbath, Ivan
El-Khoueiry, Anthony B.
Philip, Philip Agop
Moran, Susan
Ye, Yining
Soifer, Harris S.
Li, Gary
Berman, Craig
Javle, Milind M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] James Canc Hosp, Ohio State Comprehens Canc Ctr, Columbus, OH USA
[4] Univ Hosp Heidelberg, Heidelberg, Germany
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[6] Hosp Valle De Hebron, Barcelona, Spain
[7] Univ Calif Los Angeles, Santa Monica, CA USA
[8] Klinikum Univ Koln, Cologne, Germany
[9] Massachusetts Gen Hosp, Boston, MA 02114 USA
[10] Natl Univ Canc Inst, Singapore, Singapore
[11] Clin Univ St Luc bruxelles, Brussels, Belgium
[12] USC, Kenneth Norris Comprehens Canc Ctr, Los Angeles, CA USA
[13] Karmanos Canc Inst, Detroit, MI USA
[14] QED Therapeut Inc, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
579
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Next-generation sequencing (NGS) of cell-free circulating tumor DNA and tumor tissue in patients with advanced urothelial cancer: a pilot assessment of concordance
    Barata, P. C.
    Koshkin, V. S.
    Funchain, P.
    Sohal, D.
    Pritchard, A.
    Klek, S.
    Adamowicz, T.
    Gopalakrishnan, D.
    Garcia, J.
    Rini, B.
    Grivas, P.
    ANNALS OF ONCOLOGY, 2017, 28 (10) : 2458 - 2463
  • [32] Consistency Analysis of Mutations in Tumor Tissue and Circulating Cell-Free DNA in Lung Cancer Patients Through next Generation Sequencing
    Tian, G.
    Li, X.
    Liu, C.
    Xie, Y.
    Xu, F.
    Yu, D.
    Tu, X.
    Yao, X.
    He, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1863 - S1863
  • [33] Quality of life (QoL) outcomes with futibatinib treatment in FOENIX-CCA2-A phase II study in patients (pts) with intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 gene fusions/rearrangements
    Valle, J. W.
    Hollebecque, A.
    Furuse, J.
    Goyal, L.
    Meric-Bernstam, F.
    Morlock, R.
    He, Y.
    Benhadji, K.
    Bridgewater, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S263 - S264
  • [34] Comparing Next-Generation Sequencing (NGS) Platforms in Patients with Thoracic Tumors: Tumor Tissue vs. Circulating Cell-Free DNA from Blood
    Johnson, Melissa L.
    Nagy, Rebecca
    Dilks, Holli H.
    Lanman, Richard B.
    Talasaz, Amir A.
    Banks, Kimberly
    Swanton, Charles
    Burris, Howard
    Spigel, David R.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S653 - S653
  • [35] Phase 1/1b study evaluating KIN-3248, a next-generation, irreversible pan-FGFR inhibitor (FGFRi), in patients (pts) with advanced cholangiocarcinoma (CCA) and other solid tumors harboring FGFR2 and/or FGFR3 gene alterations
    Harding, J.
    Perez, C.
    Kato, S.
    Sharma, M.
    Garmezy, B.
    Quah, C.
    Tam, B.
    Severson, P.
    ANNALS OF ONCOLOGY, 2023, 34 : S63 - S64
  • [36] FOENIX-CCA2: A phase II, open-label, multicenter study of futibatinib in patients (pts) with intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 gene fusions or other rearrangements.
    Goyal, Lipika
    Meric-Bernstam, Funda
    Hollebecque, Antoine
    Valle, Juan W.
    Morizane, Chigusa
    Karasic, Thomas Benjamin
    Furuse, Junji
    He, Yaohua
    Soni, Nital
    Benhadji, Karim A.
    Bridgewater, John A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] Detecting circulating microbial cell-free DNA by next-generation sequencing in patients with Mycobacterium avium complex-lung disease: A pilot study
    Tseng, Yen-Han
    Pan, Sheng-Wei
    Feng, Jia-Yih
    Su, Wei-Juin
    Huang, Chi-Ying F.
    Chen, Yuh-Min
    TZU CHI MEDICAL JOURNAL, 2024, 36 (01): : 67 - 75
  • [38] Next-generation sequencing (NGS) analysis from a phase II single-agent gedatolisib study in patients with endometrial cancer
    Pathan, Nuzhat
    English, Patricia
    Ching, Keith
    Huang, Stephen
    Jalaie, Mehran
    Pierce, Kristen
    Vermette, Jennifer
    CANCER RESEARCH, 2016, 76
  • [39] Analysis of genomic alterations detected by next-generation sequencing-based tissue and circulating tumour DNA assays in Mexican patients with diverse type of malignant tumours
    Gonzalez Espinoza, I. R. R.
    Cortes Escobar, N.
    Garibay Diaz, J. C.
    Ibarra Fernandez, R.
    Sanchez Sosa, S.
    Gozalishvili Boncheva, A.
    Ponce de Leon, E. Acosta
    Gonzalez Blanco, M. D. J.
    Aguilar Jimenez, C.
    Miguel Cruz, E.
    Sabate Fernandez, M.
    Garcia Reyna, J. C.
    Dominguez Peregrina, A.
    Ceja Utrera, F. J.
    Arizpe Bravo, D.
    Lujano de los Santos, M.
    Cervantes Gomez, L.
    Perez Mena, L.
    Sorroza Lopez, C. A.
    Aguilar Priego, J. M.
    ANNALS OF ONCOLOGY, 2020, 31 : S297 - S297
  • [40] Comparative Analysis of Copy Number Variants (CNVs) in Cell-Free DNA (cfDNA) from Metastatic Prostate Cancer Patients Using Internal Standards versus Next-Generation Sequencing (NGS)
    Kohli, M.
    Nix, D.
    Dalley, B.
    Hanson, C.
    Ampaw, E.
    Larsen, M.
    Austermiller, B.
    Morrison, T.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S113 - S113
12345